Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boehringer wins FDA approval for its Pradaxa antidote with eyes on a bigger market share
Boehringer wins FDA approval for its Pradaxa antidote with eyes on a bigger market share
Boehringer wins FDA approval for its Pradaxa antidote with eyes on a bigger market share
Submitted by
admin
on October 17, 2015 - 3:30pm
Source:
Fierce Biotech
News Tags:
Boehringer Ingelheim
FDA
Pradaxa
bloodthinners
Praxbind
Headline:
Boehringer wins FDA approval for its Pradaxa antidote with eyes on a bigger market share
Do Not Allow Advertisers to Use My Personal information
